The first-of-its-kind respiratory syncytial virus vaccine developed by artificial intelligence has shown good results.
The FDA has granted an orphan status to MIV-818 a new hepatocellular carcinoma drug manufactured by a small biotech company.
According to scientists, the new drug is chemically aggressive and it is able to get inside the cells and destroy tuberculosis bacteria.
Experts hope that the simple procedure will become standard for middle-aged people who are at risk of developing such disease.
Colorectal cancer is one of the most common cancer pathologies in both men and women. The risk of developing is 4.2% and 4.5% in women and men, respectively.
According to a recent global study by French scientists, infections are the reason for 13% of all new cancer diagnoses.
Researchers from Oxford University have initiated clinical trials of a flu vaccine that is potentially effective against all types of virus.
Can be recommended as an additional source of biologically active plant substances that promotes to carbohydrate metabolism and blood glucose normalization.
Can be recommended as a source of biologically active substances of plant origin. Helps normalization of liver function, bile passages.
The American company VBI Vaccines is developing a universal coronavirus vaccine that mimics the structure of the virus; earlier, using this technology, the company created a vaccine for hepatitis B.